1. Alzheimer’s Drugs Market Overview
1.1 Definitions and Scope
2. Alzheimer’s Drugs Market – Executive Summary
2.1 Market Size and Key Trends
2.2 Key trends by Drug Class
2.3 Key trends by Distribution Channel
2.4 Key trends by Geography
3. Alzheimer’s Drugs Market Landscape
3.1 Market Share Analysis – Key Companies
3.2 Product Benchmarking – Key Companies
3.3 Financial Analysis – Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Alzheimer’s Drugs Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. Alzheimer’s Drugs Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Alzheimer’s Drugs Market – By Drug Class (Market Size -$Million/$Billion)
6.1 Cholinergic
6.2 Memantine
6.3 Combined drug
6.4 Other drugs
7. Alzheimer’s Drugs Market – By Distribution Channel (Market Size -$Million/$Billion)
7.1 Hospital Pharmacy
7.2 Retail Pharmacy
7.3 Online Pharmacy
8. Alzheimer’s Drugs Market- By Geography (Market Size -$Million/$Billion)
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 U.K.
8.2.2 Germany
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 Rest of Asia-Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Africa
8.4.3 South America
9. Alzheimer’s Drugs Market – Entropy
10. Alzheimer’s Drugs Market Company Analysis
10.1 Company Revenue, Products, M&A, Developments
10.2 Company 1
10.3 Company 2
10.4 Company 3
10.5 Company 4
10.6 Company 5
10.7 Company 6
10.8 Company 7
10.9 Company 8
10.10 Company 9
10.11 Company 10
“*Financials for private companies would be provided on a best efforts basis”.
Report Description
Overview
알츠하이머 치료제 시장은 치매 환자의 증상 완화와 치료를 목표로 하는 다양한 약물로 구성됩니다.
Segment
주요 세그먼트는 약물 클래스(콜린성, 메만틴, 복합 약물 등)와 유통 채널(병원 약국, 소매 약국, 온라인 약국)로 나뉩니다. 약물 클래스에서는 메만틴 기반 약물이 가장 널리 사용되며, 유통 채널 중에서는 병원 약국이 주도적인 역할을 하고 있습니다. 지리적으로는 북미와 유럽이 주요 시장을 차지하고 있습니다.
Key Takeaways
알츠하이머 치료제 시장은 고령화로 인해 지속적으로 성장하고 있습니다. 새로운 약물 개발과 더불어 온라인 약국의 확대가 중요한 트렌드로 자리잡고 있으며, 특히 혁신적인 약물 클래스에 대한 연구가 지속적으로 이루어지고 있습니다.
